PetVivo Holdings, Inc. (PETV)
USD 0.63
(0.0%)
USD 0.63
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -10.49 Million USD | -21.76% |
| 2023 | -8.61 Million USD | -73.87% |
| 2022 | -4.99 Million USD | -168.29% |
| 2021 | -1.87 Million USD | -31.36% |
| 2020 | -1.49 Million USD | 63.66% |
| 2019 | -3.92 Million USD | -138.87% |
| 2018 | -1.64 Million USD | 89.5% |
| 2017 | -16.38 Million USD | -523.83% |
| 2016 | -2.5 Million USD | -108.64% |
| 2015 | -1.2 Million USD | -6006.38% |
| 2014 | -19.68 Thousand USD | 74.96% |
| 2013 | -78.59 Thousand USD | 23.08% |
| 2012 | -102.17 Thousand USD | 61.02% |
| 2011 | -262.12 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - USD | -11.98% |
| 2024 Q1 | -2.86 Million USD | -24.11% |
| 2024 Q2 | -2.91 Million USD | -26.69% |
| 2024 Q4 | -2.28 Million USD | -83.17% |
| 2024 Q3 | -1.71 Million USD | 52.64% |
| 2023 Q4 | -2.3 Million USD | -0.91% |
| 2023 Q3 | -2.28 Million USD | -9.43% |
| 2023 Q2 | -2.08 Million USD | -7.74% |
| 2023 Q1 | -1.93 Million USD | -10.46% |
| 2023 FY | - USD | -73.87% |
| 2022 Q2 | -1.08 Million USD | -115.73% |
| 2022 FY | - USD | -168.29% |
| 2022 Q1 | -504.92 Thousand USD | -56.2% |
| 2022 Q3 | -1.64 Million USD | -50.76% |
| 2022 Q4 | -1.75 Million USD | -6.87% |
| 2021 Q2 | -797.73 Thousand USD | -106.32% |
| 2021 Q1 | -386.65 Thousand USD | -1.72% |
| 2021 FY | - USD | -31.36% |
| 2021 Q3 | -364.63 Thousand USD | 54.29% |
| 2021 Q4 | -323.24 Thousand USD | 11.35% |
| 2020 FY | - USD | 63.66% |
| 2020 Q1 | -349.63 Thousand USD | 65.83% |
| 2020 Q2 | -288.57 Thousand USD | 17.46% |
| 2020 Q3 | -406.99 Thousand USD | -41.04% |
| 2020 Q4 | -380.11 Thousand USD | 6.61% |
| 2019 Q1 | -1.93 Million USD | -143.23% |
| 2019 Q4 | -1.02 Million USD | -157.7% |
| 2019 Q3 | -397.02 Thousand USD | 29.85% |
| 2019 Q2 | -565.97 Thousand USD | 70.77% |
| 2019 FY | - USD | -138.87% |
| 2018 FY | - USD | 89.5% |
| 2018 Q4 | -795.93 Thousand USD | -113.3% |
| 2018 Q3 | -373.15 Thousand USD | -145.76% |
| 2018 Q1 | -321 Thousand USD | 37.46% |
| 2018 Q2 | -151.84 Thousand USD | 52.7% |
| 2017 FY | - USD | -523.83% |
| 2017 Q1 | -428.4 Thousand USD | 59.61% |
| 2017 Q4 | -513.3 Thousand USD | -53.43% |
| 2017 Q3 | -334.55 Thousand USD | 97.7% |
| 2017 Q2 | -14.51 Million USD | -3288.88% |
| 2016 Q1 | -985.47 Thousand USD | -480.83% |
| 2016 FY | - USD | -108.64% |
| 2016 Q4 | -1.06 Million USD | -256.23% |
| 2016 Q3 | -297.73 Thousand USD | -81.82% |
| 2016 Q2 | -163.75 Thousand USD | 83.38% |
| 2015 Q2 | -105.83 Thousand USD | 88.49% |
| 2015 Q1 | -919.52 Thousand USD | -213.34% |
| 2015 FY | - USD | -6006.38% |
| 2015 Q3 | -200.81 Thousand USD | -89.74% |
| 2015 Q4 | -169.66 Thousand USD | 15.51% |
| 2014 Q4 | 811.26 Thousand USD | 630.13% |
| 2014 Q3 | -153.03 Thousand USD | 82.76% |
| 2014 Q2 | -887.74 Thousand USD | -4787.13% |
| 2014 FY | - USD | 74.96% |
| 2014 Q1 | -18.16 Thousand USD | -18.27% |
| 2013 Q1 | -22.73 Thousand USD | 48.26% |
| 2013 Q2 | -19.96 Thousand USD | 12.18% |
| 2013 Q3 | -20.54 Thousand USD | -2.91% |
| 2013 Q4 | -15.35 Thousand USD | 25.23% |
| 2013 FY | - USD | 23.08% |
| 2012 Q3 | -23.71 Thousand USD | -74.49% |
| 2012 Q2 | -13.59 Thousand USD | 35.13% |
| 2012 Q1 | -20.94 Thousand USD | -55.27% |
| 2012 FY | - USD | 61.02% |
| 2012 Q4 | -43.93 Thousand USD | -85.26% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | -170 Thousand USD | 0.0% |
| 2011 Q2 | -40.73 Thousand USD | 76.04% |
| 2011 Q3 | -35.95 Thousand USD | 11.73% |
| 2011 Q4 | -13.49 Thousand USD | 62.47% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 22.188% |
| Cerus Corporation | -26.53 Million USD | 60.452% |
| OrthoPediatrics Corp. | -8.38 Million USD | -25.218% |
| Talis Biomedical Corporation | -66.04 Million USD | 84.11% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 37.065% |
| Inogen, Inc. | -45.67 Million USD | 77.026% |
| Spectral AI, Inc. | -12.26 Million USD | 14.415% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 77.996% |
| CVRx, Inc. | -38.73 Million USD | 72.904% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -197.463% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 13.319% |
| Orthofix Medical Inc. | -86.98 Million USD | 87.935% |
| Venus Concept Inc. | -26.11 Million USD | 59.811% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 78.914% |
| Bioventus Inc. | -23.07 Million USD | 54.51% |
| BrainsWay Ltd. | -2.31 Million USD | -354.11% |
| Envoy Medical, Inc. | -18.23 Million USD | 42.458% |
| electroCore, Inc. | -17.76 Million USD | 40.909% |
| IceCure Medical Ltd | -15.25 Million USD | 31.197% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 78.906% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 37.739% |
| MaxCyte, Inc. | -44.12 Million USD | 76.218% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 10.731% |
| Nexalin Technology, Inc. | -5.69 Million USD | -84.371% |
| PAVmed Inc | -75.74 Million USD | 86.144% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 80.478% |
| RxSight, Inc. | -41.03 Million USD | 74.427% |
| Sight Sciences, Inc. | -49.41 Million USD | 78.763% |
| SI-BONE, Inc. | -34.44 Million USD | 69.534% |
| TELA Bio, Inc. | -40.63 Million USD | 74.172% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 81.999% |
| Treace Medical Concepts, Inc. | -39 Million USD | 73.097% |
| LivaNova PLC | 39.01 Million USD | 126.898% |
| 908 Devices Inc. | -34.02 Million USD | 69.157% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 90.511% |
| Nemaura Medical Inc. | -7.28 Million USD | -44.015% |
| NeuroPace, Inc. | -22.83 Million USD | 54.04% |
| LENSAR, Inc. | -8.71 Million USD | -20.433% |
| Apyx Medical Corporation | -18.11 Million USD | 42.058% |
| Cutera, Inc. | -136.56 Million USD | 92.315% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -210.488% |
| BioSig Technologies, Inc. | -28.15 Million USD | 62.721% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 517.11% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 50.0% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 102.736% |
| Axonics, Inc. | 7.77 Million USD | 234.977% |
| Outset Medical, Inc. | -153.78 Million USD | 93.176% |
| IRIDEX Corporation | -7.44 Million USD | -40.903% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 89.302% |
| IRadimed Corporation | 20.8 Million USD | 150.453% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -30.172% |
| INVO Bioscience, Inc. | -6.88 Million USD | -52.536% |
| Telesis Bio, Inc. | -40.49 Million USD | 74.083% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 128.613% |
| Varex Imaging Corporation | 67.2 Million USD | 115.617% |
| Quipt Home Medical Corp. | 44.07 Million USD | 123.813% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 3.455% |
| Pulmonx Corporation | -55.09 Million USD | 80.951% |
| Dynatronics Corporation | -976 Thousand USD | -975.246% |
| Modular Medical, Inc. | -17.1 Million USD | 38.639% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 27.549% |
| Semler Scientific, Inc. | 23.58 Million USD | 144.489% |
| InMode Ltd. | 196.28 Million USD | 105.347% |
| Bruker Corporation | 599 Million USD | 101.752% |
| Cytosorbents Corporation | -28.81 Million USD | 63.574% |
| DexCom, Inc. | 916.7 Million USD | 101.145% |
| Align Technology, Inc. | 799.03 Million USD | 101.313% |
| Viveve Medical, Inc. | -20.61 Million USD | 49.098% |
| ZimVie Inc. | 91.07 Million USD | 111.523% |
| Movano Inc. | -29.12 Million USD | 63.967% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -138.078% |
| Nexalin Technology, Inc. | -5.69 Million USD | -84.371% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -197.463% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 94.609% |
| Profound Medical Corp. | -27.12 Million USD | 61.308% |
| Insulet Corporation | 323.6 Million USD | 103.243% |
| enVVeno Medical Corporation | -25.01 Million USD | 58.052% |
| Surmodics, Inc. | 1.18 Million USD | 983.375% |
| iCAD, Inc. | -6.56 Million USD | -59.855% |
| Nuwellis, Inc. | -16.35 Million USD | 35.837% |
| Biotricity, Inc. | -8.82 Million USD | -18.874% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 89.166% |
| Aethlon Medical, Inc. | -11.84 Million USD | 11.432% |
| InspireMD, Inc. | -20.91 Million USD | 49.814% |
| PAVmed Inc. | -75.74 Million USD | 86.144% |
| BIOLASE, Inc. | -15.13 Million USD | 30.679% |
| Beyond Air, Inc. | -59.03 Million USD | 82.222% |
| FONAR Corporation | 28.25 Million USD | 137.147% |
| AxoGen, Inc. | -13.32 Million USD | 21.26% |
| Vivani Medical, Inc. | -26.6 Million USD | 60.559% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 142.763% |
| Inari Medical, Inc. | 7.11 Million USD | 247.54% |
| UFP Technologies, Inc. | 72.74 Million USD | 114.427% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -209.957% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -70.476% |
| Tenon Medical, Inc. | -15.52 Million USD | 32.416% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 31.256% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 74.697% |
| AdaptHealth Corp. | -171.09 Million USD | 93.866% |
| Sintx Technologies, Inc. | -6.6 Million USD | -59.007% |
| NanoVibronix, Inc. | -3.43 Million USD | -205.516% |
| Quanterix Corporation | -38.08 Million USD | 72.447% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 3.455% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 35081.633% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 96.215% |
| TransMedics Group, Inc. | -7.6 Million USD | -38.031% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 51.783% |
| NeuroMetrix, Inc. | -7.09 Million USD | -47.897% |
| Hyperfine, Inc. | -47.06 Million USD | 77.7% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 82.001% |
| Biomerica, Inc. | -5.99 Million USD | -75.112% |
| Bone Biologics Corporation | 479.57 Thousand USD | 2288.303% |
| AVITA Medical, Inc. | -39.56 Million USD | 73.477% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -14.407% |
| Silk Road Medical, Inc | -45.08 Million USD | 76.72% |